Revenue Summary of RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.'s latest annual revenue in 2022 was 76.76 Thousand USD , down 0.0% from previous year.
RegeneRx Biopharmaceuticals, Inc.'s latest quarterly revenue in 2023 Q3 was - USD , down 0.0% from previous quarter.
RegeneRx Biopharmaceuticals, Inc. reported a annual revenue of 76.76 Thousand USD in annual revenue 2021, down 0.0% from previous year.
RegeneRx Biopharmaceuticals, Inc. reported a annual revenue of 76.76 Thousand USD in annual revenue 2020, down -0.0% from previous year.
RegeneRx Biopharmaceuticals, Inc. reported a quarterly revenue of - USD for 2023 Q2, down -100.0% from previous quarter.
RegeneRx Biopharmaceuticals, Inc. reported a quarterly revenue of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Historical Annual Revenue of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Year	Revenue	Revenue Growth
2022	76.76 Thousand USD	0.0%
2021	76.76 Thousand USD	0.0%
2020	76.76 Thousand USD	-0.0%
2019	76.76 Thousand USD	10.18%
2018	69.66 Thousand USD	22.97%
2017	56.65 Thousand USD	-39.28%
2016	93.3 Thousand USD	53.94%
2015	60.61 Thousand USD	0.0%
2014	- USD	-100.0%
2013	29.48 Thousand USD	-97.8%
2012	1.34 Million USD	-11.16%
2011	1.51 Million USD	77.93%
2010	849.53 Thousand USD	0.0%
2009	- USD	-100.0%
2008	168.41 Thousand USD	-29.92%
2007	240.32 Thousand USD	-11.8%
2006	272.49 Thousand USD	0.0%
2005	- USD	0.0%
2004	- USD	0.0%
2003	- USD	0.0%
2002	- USD	0.0%
2001	- USD	0.0%
2000	- USD	0.0%
1999	- USD	-100.0%
1998	3265.00 USD	-98.48%
1997	215.03 Thousand USD	-60.34%
1996	542.24 Thousand USD	413.53%
1995	105.59 Thousand USD	0.0%

Year	Revenue	Revenue Growth
2023 Q1	19.19 Thousand USD	0.0%
2023 Q2	- USD	-100.0%
2023 Q3	- USD	0.0%
2022 FY	76.76 Thousand USD	0.0%
2022 Q1	19.19 Thousand USD	0.01%
2022 Q2	19.19 Thousand USD	0.0%
2022 Q3	19.19 Thousand USD	-0.01%
2022 Q4	19.19 Thousand USD	0.0%
2021 Q2	19.19 Thousand USD	0.0%
2021 Q3	19.19 Thousand USD	-0.01%
2021 FY	76.76 Thousand USD	0.0%
2021 Q4	19.19 Thousand USD	0.0%
2021 Q1	19.19 Thousand USD	0.01%
2020 Q4	19.19 Thousand USD	0.0%
2020 FY	76.76 Thousand USD	-0.0%
2020 Q1	19.19 Thousand USD	-0.01%
2020 Q2	19.19 Thousand USD	0.01%
2020 Q3	19.19 Thousand USD	-0.01%
2019 Q3	19.19 Thousand USD	0.0%
2019 Q2	19.19 Thousand USD	-0.01%
2019 Q1	19.19 Thousand USD	0.0%
2019 FY	76.76 Thousand USD	10.18%
2019 Q4	19.19 Thousand USD	0.01%
2018 Q2	12.5 Thousand USD	-33.43%
2018 Q3	19.19 Thousand USD	53.47%
2018 Q4	19.19 Thousand USD	0.01%
2018 FY	69.66 Thousand USD	22.97%
2018 Q1	18.78 Thousand USD	8.12%
2017 Q4	17.37 Thousand USD	25.25%
2017 Q3	13.86 Thousand USD	9.15%
2017 FY	56.65 Thousand USD	-39.28%
2017 Q1	12.7 Thousand USD	0.0%
2017 Q2	12.7 Thousand USD	0.0%
2016 Q3	12.7 Thousand USD	0.0%
2016 Q4	12.7 Thousand USD	0.0%
2016 Q1	55.19 Thousand USD	446.33%
2016 FY	93.3 Thousand USD	53.94%
2016 Q2	12.7 Thousand USD	-76.98%
2015 FY	60.61 Thousand USD	0.0%
2015 Q4	10.1 Thousand USD	83.34%
2015 Q1	40 Thousand USD	0.0%
2015 Q3	5510.00 USD	10.2%
2015 Q2	5000.00 USD	-87.5%
2014 Q1	- USD	100.0%
2014 Q2	- USD	0.0%
2014 Q4	- USD	0.0%
2014 FY	- USD	-100.0%
2014 Q3	- USD	0.0%
2013 Q3	- USD	0.0%
2013 Q2	- USD	-100.0%
2013 Q1	29.48 Thousand USD	-89.51%
2013 FY	29.48 Thousand USD	-97.8%
2013 Q4	-29.48 Thousand USD	0.0%
2012 Q2	541.69 Thousand USD	140.93%
2012 Q3	295.36 Thousand USD	-45.48%
2012 Q4	280.95 Thousand USD	-4.88%
2012 FY	1.34 Million USD	-11.16%
2012 Q1	224.83 Thousand USD	-22.3%
2011 Q2	588.57 Thousand USD	-2.3%
2011 FY	1.51 Million USD	77.93%
2011 Q4	289.38 Thousand USD	828.69%
2011 Q3	31.16 Thousand USD	-94.71%
2011 Q1	602.45 Thousand USD	-24.29%
2010 Q1	-22.92 Thousand USD	0.0%
2010 Q2	11.12 Thousand USD	148.54%
2010 Q3	42.69 Thousand USD	283.59%
2010 FY	849.53 Thousand USD	0.0%
2010 Q4	795.72 Thousand USD	1763.95%
2009 Q3	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	- USD	-100.0%
2009 Q2	- USD	-100.0%
2009 Q1	4.62 Million USD	-76.64%
2008 Q3	136.24 Thousand USD	0.0%
2008 Q4	19.78 Million USD	14418.76%
2008 FY	168.41 Thousand USD	-29.92%
2008 Q2	- USD	-100.0%
2008 Q1	32.16 Thousand USD	19.35%
2007 Q2	- USD	0.0%
2007 Q4	26.95 Thousand USD	-87.37%
2007 FY	240.32 Thousand USD	-11.8%
2007 Q1	- USD	0.0%
2007 Q3	213.37 Thousand USD	0.0%
2006 Q1	- USD	0.0%
2006 Q2	- USD	0.0%
2006 FY	272.49 Thousand USD	0.0%
2006 Q3	- USD	0.0%
2006 Q4	- USD	0.0%
2005 Q4	- USD	0.0%
2005 FY	- USD	0.0%
2005 Q1	- USD	-100.0%
2005 Q2	- USD	0.0%
2005 Q3	- USD	0.0%
2004 Q4	6090.00 USD	0.0%
2004 Q2	- USD	0.0%
2004 Q1	- USD	0.0%
2004 FY	- USD	0.0%
2004 Q3	- USD	0.0%
2003 Q3	- USD	0.0%
2003 FY	- USD	0.0%
2003 Q2	- USD	0.0%
2003 Q1	- USD	0.0%
2003 Q4	- USD	0.0%
2002 Q1	- USD	0.0%
2002 Q3	- USD	0.0%
2002 FY	- USD	0.0%
2002 Q2	- USD	0.0%
2002 Q4	- USD	0.0%
2001 Q1	- USD	0.0%
2001 FY	- USD	0.0%
2001 Q4	- USD	0.0%
2001 Q3	- USD	0.0%
2001 Q2	- USD	0.0%
2000 FY	- USD	0.0%
2000 Q1	- USD	0.0%
2000 Q2	- USD	0.0%
2000 Q3	- USD	0.0%
2000 Q4	- USD	0.0%
1999 Q1	- USD	0.0%
1999 Q2	- USD	0.0%
1999 Q3	- USD	0.0%
1999 Q4	- USD	0.0%
1999 FY	- USD	-100.0%
1998 FY	3265.00 USD	-98.48%
1997 FY	215.03 Thousand USD	-60.34%
1996 FY	542.24 Thousand USD	413.53%
1995 FY	105.59 Thousand USD	0.0%

Peer Revenue Comparison of RegeneRx Biopharmaceuticals, Inc.

Name	Revenue	Revenue Difference
Burzynski Research Institute, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	75.72 Thousand USD	-1.369%
Evofem Biosciences, Inc.	18.21 Million USD	99.579%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
Santhera Pharmaceuticals Holding AG	122.95 Million USD	99.938%
Qrons Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Neon Bloom, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	1.93 Million USD	96.027%
ProtoKinetix, Incorporated	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Eiger BioPharmaceuticals, Inc.	15.77 Million USD	99.513%
Nanobac Pharmaceuticals, Incorporated	17.62 Thousand USD	-335.622%
Institute of Biomedical Research Corp.	- USD	-Infinity%
SQZ Biotechnologies Company	21.47 Million USD	99.643%
Intellipharmaceutics International Inc.	65.72 Thousand USD	-16.786%
Propanc Biopharma, Inc.	- USD	-Infinity%
Mesoblast Limited	5.9 Million USD	98.699%
Marizyme, Inc.	645.81 Thousand USD	88.114%
Genus plc	668.8 Million USD	99.989%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
Pharming Group N.V.	245.31 Million USD	99.969%
Therapeutic Solutions International, Inc.	98.99 Thousand USD	22.459%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	81.285%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
ContraFect Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
IMV Inc.	- USD	-Infinity%
AXIM Biotechnologies, Inc.	39.51 Thousand USD	-94.243%
MultiCell Technologies, Inc.	49.32 USD	-155538.686%
ONE Bio Corp.	52.29 Million USD	99.853%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	49.72 Million USD	99.846%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	48.9 Thousand USD	-56.975%
Q BioMed Inc.	284.35 Thousand USD	73.005%
Emmaus Life Sciences, Inc.	29.59 Million USD	99.741%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	145.09 Million USD	99.947%
Provectus Biopharmaceuticals, Inc.	557.71 Thousand USD	86.236%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	70 Thousand USD	-9.659%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	658.5 Thousand USD	88.343%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	14.69 Billion USD	99.999%
Wesana Health Holdings Inc.	- USD	-Infinity%
Halberd Corporation	999.00 USD	-7583.784%
Enzolytics Inc.	52.79 Thousand USD	-45.392%
Agentix Corp.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Nuo Therapeutics, Inc.	608.52 Thousand USD	87.386%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	1.22 Billion USD	99.994%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	140.24 Thousand USD	45.265%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	617.38 Thousand USD	87.567%
Zenith Capital Corp.	- USD	-Infinity%
Genscript Biotech Corporation	839.52 Million USD	99.991%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	- USD	-Infinity%
WPD Pharmaceuticals Inc.	- USD	-Infinity%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Helix BioMedix, Inc.	997.72 Thousand USD	92.306%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	48.35 Million USD	99.841%
BioStem Technologies, Inc.	16.68 Million USD	99.54%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	236.56 Thousand USD	67.551%
Regen BioPharma, Inc.	236.56 Thousand USD	67.551%
NovAccess Global Inc.	- USD	-Infinity%
Affymax, Inc.	1.36 Million USD	94.393%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	473.73 Thousand USD	83.796%
SYBLEU INC	11.69 Thousand USD	-556.301%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	7.78 Million USD	99.014%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	13 Thousand USD	-490.469%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	39.53 Thousand USD	-94.165%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	3.33 Million USD	97.695%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	6.66 Million USD	98.848%
IntelGenx Technologies Corp.	1.03 Million USD	92.612%
Gelesis Holdings, Inc.	25.76 Million USD	99.702%
CSL Limited	14.8 Billion USD	99.999%
Cellectis S.A.	755 Thousand USD	89.833%

Global Stocks Search

RegeneRx Biopharmaceuticals, Inc. (RGRX)

Revenue Summary of RegeneRx Biopharmaceuticals, Inc.

Annual Revenue Chart of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Historical Annual Revenue of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Peer Revenue Comparison of RegeneRx Biopharmaceuticals, Inc.